Intra-Cellular Therapies
ITCI
$74.54
Share price
3.00%
Change (1 day)
19.74%
Change (1 year)
Categories
Intra-Cellular Therapies (ITCI) - Net assets
Net assets on the balance sheet as of December 2023 : $0.59 B
According to Intra-Cellular Therapies's latest financial reports the company has $0.59 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Intra-Cellular Therapies - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.59 B | -9.85% |
| 2022-12-31 | $0.65 B | 57% |
| 2021-12-31 | $0.41 B | -36.38% |
| 2020-12-31 | $0.65 B | 236.84% |
| 2019-12-31 | $0.19 B | -38.62% |
| 2018-12-31 | $0.31 B | -30.09% |
| 2017-12-31 | $0.45 B | 21.02% |
| 2016-12-31 | $0.37 B | -21.15% |
| 2015-12-31 | $0.47 B | 295.04% |
| 2014-12-31 | $0.12 B | 281.32% |
| 2013-12-31 | $31.61 M | 86.15% |
| 2013-03-31 | $-0.03 M | |
| 2012-12-31 | $16.98 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | $0.66 B | 13.14% | 🇺🇸 USA |
 MediciNova MNOV | $62.37 M | -89.45% | 🇺🇸 USA |
 Curis CRIS | $19.67 M | -96.67% | 🇺🇸 USA |